Project CBD

MARCH 21, 2023

Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

FloridaMarijuana.net

JUNE 13, 2018

More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Additionally, the NCI recognizes that cannabinoids “may have benefits in the treatment of cancer-related side effects.”. For centuries, humans have relied on the cannabis plant for its therapeutic properties.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

MMJ Recs

MAY 9, 2024

In this instance, medical cannabis offers a promising alternative or complementary treatment option. For veterans considering medical marijuana as a treatment option, it’s essential to approach its usage with careful consideration and understanding. Image by National Cancer Institute on Unsplash.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

AUGUST 17, 2021

Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Veriheal

JANUARY 28, 2022

The cannabis compound cannabidivarin (CBDV) has already been found to be a promising treatment for ASD, particularly in terms of repetitive behaviors, irritability, social functioning, and inflammation. A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D. However, THC is more widely available.

Oil 99

Oil THC Research and Development Treatment 99

MMJ Recs

DECEMBER 17, 2023

To qualify for the program, patients must have explored other treatment options unsuccessfully and be under the care of a qualified physician. In Texas, the allowable THC concentration is capped at a very low level, differentiating it from traditional medicinal cannabis programs in other states.

Law 52

Law Dispensary Clinical Trials Programs 52

FloridaMarijuana.net

AUGUST 9, 2018

Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. Relieve pain, inflammation and nausea.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

The Cannigma

JULY 20, 2021

A review based on seven different clinical trials concluded that “Silexan is a safe and effective treatment in anxiety disorders” 6. Cannabis strains often have one dominant terpene with concentrations above 1% and a few more with more modest concentrations between 0.1

Strains 145

Strains Terpenes Concentrates THC 145

Cannabis Law Report

JANUARY 12, 2022

. “Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. ” Gb Sciences’ intellectual property portfolio includes five U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. On track to commence Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end. The founding co-chairs are Andrew Monte, M.D., and Arjun Chanmugam, M.D.,

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

CannaMD

MAY 25, 2021

The cannabinoid receptor known as CB1 , which occurs in heavy concentration in the brain, was identified as playing a role in pathophysiological events ranging from memory deficits to neurodegenerative disorders. In their summary, the study’s authors noted that. CBD alone is sufficiently effective in enhancing fracture healing.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. The researchers added that people in treatment for AUD might benefit from stopping or reducing their cannabis use.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

Peninsula Alternative Health

MAY 15, 2019

With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one. Following the treatment period, there was a 35.5%

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Canna Law Blog

JANUARY 25, 2019

” After all, it is is a concentrate of a botanical: hemp. For example, two such substantial clinical investigations include GW Pharmaceuticals’ investigations regarding Sativex and Epidiolex. In addition, anything intended as a component of a drug is also drug. 21 USC § 321(g). 21 U.S.C. §

Hemp 97

Hemp CBD Clinical Trials Food 97

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. It is a serious medical condition that requires appropriate treatment and support. Furthermore, conventional treatments often focus on symptom management rather than addressing the root causes of OCD.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

FloridaMarijuana.net

OCTOBER 19, 2018

Decreased energy, fatigue, feeling “slowed down” Difficulty concentrating, remembering, making decisions. Persistent physical symptoms that do not respond to treatment, such as headaches, digestive disorders and pain for which no other cause can be determined. Insomnia, early-morning awakening, or oversleeping.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

Cannabis Law Report

JULY 29, 2021

In Ontario, Heritage achieved fastest growing concentrate sales and grew to #5 and #6 in sales in the concentrate category within one month of launching in the province. of the market share in the concentrates category, and RAD alone grew from 7.5% Sales of vape products in Q3 increased 119% quarter-over-quarter in the B.C.

Recreational 98

Recreational Vaping Concentrates Clinical Trials 98

Cannabis Law Report

DECEMBER 11, 2021

Department records show that the health condition of 74% of patients improves after such treatment. “Our plan is to open more cannabis clinics to cover most of the tambons across the nation,” Dr Kwanchai said. Can you elaborate on the cannabis oil treatment available at these clinics? The first is Daycha Oil.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Otherside Farms

JANUARY 14, 2019

While there is a need for more clinical trials on the subject, users and alternative-therapy practitioners worldwide continue to buy cannabis seeds online for healing physical and mental ailments. Here are five popular medicinal uses of cannabis with low concentration of the intoxicating chemical compound tetrahydrocannabinol (THC).

Clinical Trials 49

Clinical Trials Strains Therapy Medicine 49

Puff Puff Post

JANUARY 13, 2020

This way the doctors know what the concentrations are of the active ingredients and how they might best help their patients. Currently, researchers at a number of university hospitals are investigating CBD’s potential usage as a treatment for autism. Cannabidiol As Treatment For Opiate and Alcohol Addiction. Physicians at Mt.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

This way the doctors know what the concentrations are of the active ingredients and how they might best help their patients. Currently, researchers at a number of university hospitals are investigating CBD’s potential usage as a treatment for autism. Cannabidiol As Treatment For Opiate and Alcohol Addiction. Physicians at Mt.

CBD 52

CBD Clinical Trials Research and Development Oil 52

The Cannigma

MAY 6, 2021

Delta-9-THC and CBD can be found in concentrations as high as 20% and even 30%, but minor cannabinoids such as delta-8-THC generally occur in concentrations below 1%. had no measurable concentrations of delta-8-THC. Of the ones that did contain delta-8, the average concentration was only about 0.0018%”. Shutterstock).

THC 145

THC Cannabinoids Concentrates Hemp 145

Cannabis Law Report

DECEMBER 21, 2021

In most fully developed cannabis plants with considerable THC and CBD concentrations, CBG levels are relatively low. They concluded that CBG should be evaluated for clinical trials in individuals with IBD. They proposed that the use of CBG in the treatment and prevention of colon cancer should be investigated further.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

The first-ever cannabis-based drug with FDA approval is Epidiolex*, a new prescription drug designed to treat severe seizure disorders that do not respond to other treatments. Repeat seizures can result in a life-threatening condition called status epilepticus that requires emergency medical treatment. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

OCTOBER 22, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. 9-THC) and Cannabidiol (CBD) in a 1:20 ratio and at a concentration of 30% CBD and 1.5% ?9-THC. Avidekel oil containing ?9-Tetra-Hydrocannabinol

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

The Joint Blog

NOVEMBER 26, 2019

However, cannabis does not lead to the medication overuse headache that is associated with other conventional treatments, meaning that use of cannabis does not make headaches or migraines worse over time. Finally, we explored evidence for tolerance to these effects. Further, there was evidence of tolerance to these effects.

Clinical Trials 55

Clinical Trials Research and Development Marijuana Data 55

Cannabis Law Report

DECEMBER 28, 2021

There were no treatment-related clinical observations, changes in body weight, or dermal irritation observed. The maximum plasma concentration (Cmax) was reached at 4 hours post-dose, and concentrations of plasma Epoladerm remained at 24-hour post-dose for all animals. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Peninsula Alternative Health

MAY 15, 2019

With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one. Following the treatment period, there was a 35.5%

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Project CBD

FEBRUARY 28, 2023

According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3% 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e.,

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

LifeCannMD

AUGUST 23, 2021

Those with more severe sleep issues such as insomnia have trouble concentrating during the day and the lack of rest often affects mood. CBD is an increasingly popular alternative to traditional sleep medications and treatments. Most clinical trials have involved doses between 25 to 1,500 mg.

CBD 52

CBD Sleep Clinical Trials Cannabinoids 52

Cannabis Law Report

NOVEMBER 29, 2019

This explains why THC affects thinking, pleasure, memory, concentration, sensory, time perception, movements, and coordination. For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. THC has also been touted as a potential treatment for cancer.

Oil 104

Oil THC Cannabinoids Research and Development 104

Cannabis Law Report

OCTOBER 18, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. 9-THC) and Cannabidiol (CBD) in a 1:20 ratio and at a concentration of 30% CBD and 1.5% ?9-THC. Lenabasum: Corbus Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52